Baseline Prevalence and Emergence of Protease Inhibitor Resistance Mutations Following Treatment in Chronic HCV Genotype 1-Infected Individuals
Antiviral Therapy - United Kingdom
doi 10.3851/imp2964
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
International Medical Press